Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer. [electronic resource]
Producer: 20080215Description: 2959-66 p. digitalISSN:- 1535-7163
- Animals
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- pharmacology
- Ascites -- pathology
- Bevacizumab
- Body Weight -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Disease Models, Animal
- Female
- Humans
- Mice
- Mice, SCID
- Neoplasm Proteins -- metabolism
- Ovarian Neoplasms -- pathology
- Peritoneal Neoplasms -- pathology
- Sirolimus -- pharmacology
- Tumor Burden -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.